Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Daperno

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Alimentary Pharmacology & Therapeutics|October 25, 2021
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD studyCristina Bezzio, Alessandro Armuzzi, Federica Furfaro, et al.
Alimentary Pharmacology & Therapeutics|July 25, 2022
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE studyDaniela Pugliese, Giuseppe Privitera, Federica Crispino, et al.
Gastroenterology|September 15, 2007
Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel diseaseMauro D'Amato, Sara Bruce, Francesca Bresso, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 20, 2021
Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in ItalyAlessandro Vitello, Mauro Grova, Daniela Pugliese, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 6, 2017
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)Livia Biancone, Vito Annese, Sandro Ardizzone, et al.
Journal of Crohn'S & Colitis|March 3, 2016
Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD StudyLivia Biancone, Alessandro Armuzzi, Maria Lia Scribano, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 12, 2023
Standardizing Scoring Conventions for Crohn's Disease Endoscopy: An International RAND/UCLA Appropriateness StudyReena Khanna, Christopher Ma, Malcolm Hogan, et al.
United European Gastroenterology Journal|February 23, 2022
PICaSSO virtual electronic chromendoscopy accurately reflects combined endoscopic and histological assessment for prediction of clinical outcomes in ulcerative colitisOlga Maria Nardone, Alina Bazarova, Pradeep Bhandari, et al.
Gut|May 2, 2020
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD studyCristina Bezzio, Simone Saibeni, Angela Variola, et al.
Gastroenterology|December 21, 2020
An International Multicenter Real-Life Prospective Study of Electronic Chromoendoscopy Score PICaSSO in Ulcerative ColitisMarietta Iacucci, Samuel C L Smith, Alina Bazarova, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Alimentary Pharmacology & Therapeutics|October 25, 2021
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD studyCristina Bezzio, Alessandro Armuzzi, Federica Furfaro, et al.
Alimentary Pharmacology & Therapeutics|July 25, 2022
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE studyDaniela Pugliese, Giuseppe Privitera, Federica Crispino, et al.
Gastroenterology|September 15, 2007
Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel diseaseMauro D'Amato, Sara Bruce, Francesca Bresso, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 20, 2021
Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in ItalyAlessandro Vitello, Mauro Grova, Daniela Pugliese, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 6, 2017
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)Livia Biancone, Vito Annese, Sandro Ardizzone, et al.
Journal of Crohn'S & Colitis|March 3, 2016
Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD StudyLivia Biancone, Alessandro Armuzzi, Maria Lia Scribano, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 12, 2023
Standardizing Scoring Conventions for Crohn's Disease Endoscopy: An International RAND/UCLA Appropriateness StudyReena Khanna, Christopher Ma, Malcolm Hogan, et al.
United European Gastroenterology Journal|February 23, 2022
PICaSSO virtual electronic chromendoscopy accurately reflects combined endoscopic and histological assessment for prediction of clinical outcomes in ulcerative colitisOlga Maria Nardone, Alina Bazarova, Pradeep Bhandari, et al.
Gut|May 2, 2020
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD studyCristina Bezzio, Simone Saibeni, Angela Variola, et al.
Gastroenterology|December 21, 2020
An International Multicenter Real-Life Prospective Study of Electronic Chromoendoscopy Score PICaSSO in Ulcerative ColitisMarietta Iacucci, Samuel C L Smith, Alina Bazarova, et al.
Pageof 10